1026200-27-0

Basic information

• Product Name: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-
• Synonyms: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-;(S)-3,3-dimethyl-2-((((1R,2R)-2-(pent-4-en-1-yl)cyclopropoxy)carbonyl)amino)butanoic acid;ZWQXCSWBZGSXDK-IJLUTSLNSA-N
• CAS NO: 1026200-27-0
• Molecular Formula: C₁₅H₂₅NO₄
• Molecular Weight: 283.3633
• Mol File: 1026200-27-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-(1026200-27-0)
• EPA Substance Registry System: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-(1026200-27-0)

Safety Data

• Hazardous Substances Data: 1026200-27-0(Hazardous Substances Data)

Usage

Description

L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]is a unique L-amino acid derivative with a complex chemical structure. As an essential amino acid, L-Valine is vital for various biological processes, including muscle metabolism, tissue repair, and maintaining nitrogen balance in the body. The additional 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]group suggests potential involvement in enzyme regulation or nerve signal transmission, indicating its significance in pharmaceuticals, biochemistry, and nutrition.

Uses

Used in Pharmaceutical Industry:
L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]is used as a pharmaceutical compound for its potential role in enzyme regulation and nerve signal transmission. Its complex structure may contribute to the development of new drugs targeting specific biological processes.
Used in Biochemistry Research:
In the field of biochemistry, L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]is utilized as a research tool to study the mechanisms of enzyme regulation and nerve signal transmission. Its unique structure allows scientists to explore its interactions with other biomolecules and understand its role in various biological processes.
Used in Nutritional Supplements:
L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]is used as a nutritional supplement to support muscle metabolism, tissue repair, and maintain nitrogen balance in the body. Its essential nature makes it a crucial component in dietary supplements, particularly for individuals with specific dietary requirements or those seeking to optimize their protein intake.

Upstream product

• 1026200-25-8 methyl 3-methyl-N-({[(1R,2R)-2-pent-4-en-1-ylcyclopropyl]oxy}carbonyl)-L-valinate 
• 1384277-05-7 trans 2-(pent-4-en-1-yl)cyclopropanol 
• 63038-27-7 L-tert-leucine methyl ester hydrochloride 
• 144164-32-9 methyl 3-methyl-N-(oxomethylene)-L-valinate 
• 124471-62-1 (E)-(hepta-1,6-dien-1-yloxy)trimethylsilane 
• 1263814-64-7 C₁₃H₁₇NO₅ 
• 1206524-77-7 (1R,2R)-2-(pent-4-en-1-yl)cyclopropanol 

Downstream Products

• 1350514-68-9 grazoprevir 
• 1206524-84-6 methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxa-diazacyclononadecino[11,12-b]quinoxaline-8-carboxylate 
• 1206524-85-7 (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradeca-hydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid hydrate 
• 1206524-83-5 methyl (1aR,5S,8S,10R,18E,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,20,21,22,22a-dodecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylate 
• 1535212-06-6 C₃₁H₄₀F₂N₄O₇ 
• 1535212-07-7 (1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide 
• 1206524-81-3 (2S,4R)-methyl 4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-1-((S)-3,3-dimethyl-2-((((1R,2R)-2-(pent-4-en-1-yl)cyclopropoxy)carbonyl)amino)butanoyl)pyrrolidine-2-carboxylate 

Relevant articles and documents

INHIBITORS OF HEPATITIS C VIRUS

Compounds of Formula I are disclosed, As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors

The present invention relates to macrocyclic a compound of formula (I) and its use as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections.